Setmelanotide
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Rhythm · Phase 3 · Active, not recruiting · Enrollment 143
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Setemelanotide | n/r | n/r | n/r | n/r | n/r |
| Placebo | 17 participants | 14 participants | 14 participants | n/r | 0 |
| Setmelanotide | 49 participants | 36 participants | 19 participants | n/r | 2 |
A count stays a count. This page does not turn a count into a percent.